DMED — Diagnamed Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- CA$1.61m
- CA$1.23m
Annual cashflow statement for Diagnamed Holdings, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -1.95 | -1.13 | -1.28 |
| Non-Cash Items | 1.26 | 0.139 | 0.06 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.118 | 0.206 | 0.15 |
| Change in Accounts Receivable | |||
| Change in Payable / Accrued Expenses | |||
| Cash from Operating Activities | -0.566 | -0.788 | -1.07 |
| Other Investing Cash Flow Items | 0.034 | 0 | — |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | 0.034 | 0 | — |
| Net Issuance / Retirement of Stock | |||
| Cash from Financing Activities | 2.89 | 0 | 0.104 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 2.36 | -0.788 | -0.963 |